Literature DB >> 15632058

ROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation.

Bok Yun Kang1, Shi-Chuen Miaw, I-Cheng Ho.   

Abstract

ROG, a transcriptional repressor, is a direct target gene of NF-AT and a putative negative regulator of T-cell activation. In addition, overexpression of ROG suppresses the activity of GATA-3, implying a role of ROG in the differentiation and function of Th cells. Despite these observations, the function of ROG has yet to be confirmed by loss-of-function approaches. Here we report that ROG-deficient T cells are hypersensitive to anti-CD3 stimulation and produce more interleukin-2 (IL-2) due to enhanced NF-kappaB activity. ROG-deficient dendritic cells also produce more IL-12p40, another NF-kappaB target gene. However, ROG-deficient Th cells are capable of differentiating into Th1 and Th2 cells, and ROG-deficient mice have no defect in mounting appropriate Th immune responses in vivo. Thus, ROG is dispensable for the differentiation and function of Th cells but serves as a mediator of NF-AT-initiated suppression of NF-kappaB. Its mechanism of action and its expression pattern are distinct from those of other transcription factors negatively regulating the activation of T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632058      PMCID: PMC543427          DOI: 10.1128/MCB.25.2.554-562.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment.

Authors:  W Ouyang; M Löhning; Z Gao; M Assenmacher; S Ranganath; A Radbruch; K M Murphy
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

Review 3.  Lineage commitment in the immune system: the T helper lymphocyte grows up.

Authors:  L H Glimcher; K M Murphy
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

4.  GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells.

Authors:  Sung-Yun Pai; Morgan L Truitt; I-Cheng Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

5.  LKLF: A transcriptional regulator of single-positive T cell quiescence and survival.

Authors:  C T Kuo; M L Veselits; J M Leiden
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.

Authors:  V S Shapiro; K E Truitt; J B Imboden; A Weiss
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

7.  Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.

Authors:  K L McGuire; M Iacobelli
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

8.  ROG, repressor of GATA, regulates the expression of cytokine genes.

Authors:  S C Miaw; A Choi; E Yu; H Kishikawa; I C Ho
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

9.  Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene.

Authors:  D H Zhang; L Cohn; P Ray; K Bottomly; A Ray
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

10.  Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development.

Authors:  A M Ranger; M Oukka; J Rengarajan; L H Glimcher
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

View more
  18 in total

1.  T cell and APC dynamics in situ control the outcome of vaccination.

Authors:  Kamal M Khanna; David A Blair; Anthony T Vella; Stephen J McSorley; Sandip K Datta; Leo Lefrançois
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  ZBTB32 Restricts the Duration of Memory B Cell Recall Responses.

Authors:  Arijita Jash; Yinan Wang; Florian J Weisel; Christopher D Scharer; Jeremy M Boss; Mark J Shlomchik; Deepta Bhattacharya
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

3.  Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα.

Authors:  Bo Sun; Nishant Dwivedi; Tyler J Bechtel; Janet L Paulsen; Aaron Muth; Mandar Bawadekar; Gang Li; Paul R Thompson; Miriam A Shelef; Celia A Schiffer; Eranthie Weerapana; I-Cheng Ho
Journal:  Sci Immunol       Date:  2017-06-09

4.  Analysis of uterine gene expression in interleukin-15 knockout mice reveals uterine natural killer cells do not play a major role in decidualization and associated angiogenesis.

Authors:  Brent M Bany; Charles A Scott; Kirsten S Eckstrum
Journal:  Reproduction       Date:  2011-12-20       Impact factor: 3.906

Review 5.  The BTB-ZF transcription factors.

Authors:  Owen M Siggs; Bruce Beutler
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 6.  Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell development.

Authors:  Michael J Shapiro; Virginia Smith Shapiro
Journal:  Cytokine       Date:  2010-12-16       Impact factor: 3.861

7.  The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system.

Authors:  Aimee M Beaulieu; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2011-09-15       Impact factor: 5.422

8.  Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.

Authors:  Jessica C de Greef; Jun Wang; Judit Balog; Johan T den Dunnen; Rune R Frants; Kirsten R Straasheijm; Caner Aytekin; Mirjam van der Burg; Laurence Duprez; Alina Ferster; Andrew R Gennery; Giorgio Gimelli; Ismail Reisli; Catharina Schuetz; Ansgar Schulz; Dominique F C M Smeets; Yves Sznajer; Cisca Wijmenga; Marja C van Eggermond; Monique M van Ostaijen-Ten Dam; Arjan C Lankester; Maarten J D van Tol; Peter J van den Elsen; Corry M Weemaes; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2011-05-19       Impact factor: 11.025

Review 9.  Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.

Authors:  Chie Hotta-Iwamura; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2016-01-20       Impact factor: 4.962

10.  ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.

Authors:  Hye Suk Yoon; Christopher D Scharer; Parimal Majumder; Carl W Davis; Royce Butler; Wendy Zinzow-Kramer; Ioanna Skountzou; Dimitrios G Koutsonanos; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.